|Articles|April 1, 2004
Criteria for new quality-of-life tool patient-oriented
San Francisco - The problem with many existing techniques for gauging the negative impact on quality of life of psoriasis is that their criteria are defined by doctors, not patients. However, PQOL-12 reverses this situation, thereby providing what is perhaps the most accurate and meaningful scale yet.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
JAK Inhibitors Show Comparable Safety to TNF Antagonists
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Considering Biologics and Shared Decision-Making in Moderate to Severe Plaque Psoriasis: Part 2
4
"PDE4 Inhibitor-Responsive Dermatoses": A Modern Framework for Managing Inflammatory Skin Conditions
5














